BID | 94.93 | ASK | 94.95 | ||
Open | 94.98 | Previous Close | 94.97 | ||
Pre-Market | - | After-Market | - | ||
- - | - -% |
Target Price | 88.62 | Analyst Rating | — — 0.00 | |
Potential % | - | Finscreener Ranking | + — - | |
Insiders Trans % 3/6/12 mo. | -100/-100/-100 | Value Ranking | ★ — - | |
Insiders Value % 3/6/12 mo. | -100/-100/-100 | Growth Ranking | ★★★★ — - | |
Insiders Shares Cnt. % 3/6/12 mo. | -100/-100/-100 | Income Ranking | ★ — - | |
Price Range Ratio 52W % | 0.00 | Earnings Rating | Buy | |
Market Cap | 27.92B | Earnings Date | 29th Jul 2022 | |
Alpha | 0.00 | Standard Deviation | 0.07 | |
Beta | 0.72 |
Today's Price Range 94.9294.99 | 52W Range 69.0895.40 | 5 Year PE Ratio Range 19.0049.00 |
Summary:
Neutral
Technical Indicators: | Sell |
Moving Averages: | Strong Buy |
Performance | |||
---|---|---|---|
1 Week | - | ||
1 Month | - | ||
3 Months | 0.98% | ||
6 Months | 3.78% | ||
1 Year | 19.41% | ||
3 Years | 34.64% | ||
5 Years | 50.48% | ||
10 Years | 161.85% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | 8.30 | |||
ROE last 12 Months | 14.77 | |||
ROA (5Y Avg) | 4.77 | |||
ROA last 12 Months | 7.94 | |||
ROC (5Y Avg) | 11.10 | |||
ROC last 12 Months | 10.30 | |||
Return on invested Capital Q | 3.81 | |||
Return on invested Capital Y | 3.12 | |||
Assets Turnover | 0.80 | |||
Receivables Turnover | 5.10 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
47.70 | ||||
7.14 | ||||
4.81 | ||||
16.70 | ||||
34.00 | ||||
5.80 | ||||
20.83 | ||||
13.05 | ||||
28.65B | ||||
Forward PE | 27.44 | |||
PEG | 3.73 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
1.50 | ||||
1.80 | ||||
0.29 | ||||
0.41 | ||||
18.30 | ||||
Leverage Ratio | 1.90 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
82.50 | ||||
13.40 | ||||
25.80 | ||||
14.50 | ||||
10.24 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
5.81B | ||||
19.74 | ||||
1.27 | ||||
2.87 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
1.14 | ||||
1.08 | ||||
- | ||||
- | ||||
Payout ratio | 36.00 |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q01 2022 | 0.75 | 0.78 | 4.00 |
Q04 2021 | 0.75 | 0.82 | 9.33 |
Q03 2021 | 0.69 | 0.70 | 1.45 |
Q02 2021 | 0.65 | 0.66 | 1.54 |
Q01 2021 | 0.64 | 0.64 | 0.00 |
Q04 2020 | 0.69 | 0.67 | -2.90 |
Q03 2020 | 0.62 | 0.60 | -3.23 |
Q02 2020 | 0.53 | 0.53 | 0.00 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
6/2022 QR | 0.74 | 0.00 | - |
9/2022 QR | 0.78 | 0.00 | - |
12/2022 FY | 3.14 | 0.64 | Positive |
12/2023 FY | 3.46 | -1.98 | Negative |
Next Report Date | - |
Estimated EPS Next Report | 0.74 |
Estimates Count | 3 |
EPS Growth Next 5 Years % | 12.80 |
Volume Overview | |
---|---|
Volume | 34.52M |
Shares Outstanding | 294.10K |
Shares Float | 262.24M |
Trades Count | 25.52K |
Dollar Volume | 3.28B |
Avg. Volume | 3.43M |
Avg. Weekly Volume | 4.39M |
Avg. Monthly Volume | 3.11M |
Avg. Quarterly Volume | 2.79M |
Cerner Corporation (NASDAQ: CERN) stock closed at 94.92 per share at the end of the most recent trading day (a -0.05% change compared to the prior day closing price) with a volume of 34.52M shares and market capitalization of 27.92B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 26400 people. Cerner Corporation CEO is Brent Shafer.
The one-year performance of Cerner Corporation stock is 19.41%, while year-to-date (YTD) performance is 2.21%. CERN stock has a five-year performance of 50.48%. Its 52-week range is between 69.08 and 95.4, which gives CERN stock a 52-week price range ratio of %
Cerner Corporation currently has a PE ratio of 47.70, a price-to-book (PB) ratio of 7.14, a price-to-sale (PS) ratio of 4.81, a price to cashflow ratio of 16.70, a PEG ratio of 2.32, a ROA of 7.94%, a ROC of 10.30% and a ROE of 14.77%. The company’s profit margin is 10.24%, its EBITDA margin is 25.80%, and its revenue ttm is $5.81 Billion , which makes it $19.74 revenue per share.
Of the last four earnings reports from Cerner Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.74 for the next earnings report. Cerner Corporation’s next earnings report date is -.
The consensus rating of Wall Street analysts for Cerner Corporation is — (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Cerner Corporation stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Cerner Corporation has a dividend yield of 1.14% with a dividend per share of $1.08 and a payout ratio of 36.00%.
Cerner Corporation has a Neutral technical analysis rating based on Technical Indicators (ADX : 11.02, ATR14 : 0.28, CCI20 : 99.81, Chaikin Money Flow : -0.21, MACD : 0.31, Money Flow Index : 42.81, ROC : 1.06, RSI : 66.03, STOCH (14,3) : 71.08, STOCH RSI : 0.53, UO : 51.36, Williams %R : -28.92), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Cerner Corporation in the last 12-months were: Daniel P. Devers (Option Excercise at a value of $3 571 650), Daniel P. Devers (Sold 60 174 shares of value $5 471 072 ), David T. Feinberg (Option Excercise at a value of $0), Jerome Labat (Option Excercise at a value of $0), Mark J. Erceg (Option Excercise at a value of $0), Michael R. Battaglioli (Option Excercise at a value of $204 631), Michael R. Battaglioli (Sold 10 788 shares of value $935 898 ), Tracy L. Platt (Option Excercise at a value of $0), Tracy L. Platt (Sold 7 769 shares of value $725 625 ), Travis S. Dalton (Option Excercise at a value of $0)
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | - | - | - |
Cerner is a leading supplier of healthcare information technology solutions and tech-enabled services. The company is a long-standing market leader in the electronic health record industry, and along with rival Epic Systems corners a majority of the market for acute care EHR within health systems. The company is guided by the mission of the founding partners to provide seamless medical records across all healthcare providers to improve outcomes. Beyond medical records, the company offers a wide range of technology that supports the clinical, financial, and operational needs of healthcare facilities.
CEO: Brent Shafer
Telephone: +1 816 221-1024
Address: 2800 Rockcreek Parkway, North Kansas City 64117, MO, US
Number of employees: 26 400
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. CBOE EDGX Top real-time data for Premium users, NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Technology and data provided by TeleTrader. Conditions of Use. The regulations of the respective stock are to be observed. Copyright © 2022. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer. The Cryptocurrency Market real-time data provided by Cryptocompare.com
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.